On August 31, 2010, the U. S. Food and Drug Administration (FDA) approved the first generic version of Olanzapine, a medication used to treat major depressive disorder (MDD). The drug was the second of its kind, and is a type of prescription medication. The approval was the first of its kind for the treatment of schizophrenia. It has a long history of success as an effective and safe treatment for schizophrenia, but has since been withdrawn from the market due to safety concerns.
In January 2010, the FDA began to evaluate the safety and effectiveness of the generic version of Olanzapine. In April 2010, the FDA announced that it had concluded that the FDA’s decision was not necessary and that it was “unnecessary” to provide a generic version of the drug. On July 9, 2010, the FDA announced that it was withdrawing the first generic version of Olanzapine from the market, pending further evaluation of the generic’s safety and effectiveness. The FDA’s decision to withdraw the generic was announced by the FDA’s Chairman and President, Dr. Sarah Hamburg.
A few months later, on July 24, 2010, the FDA announced that it had concluded that the company’s product labeling for the generic version of Olanzapine contained incorrect information about the efficacy and safety of the generic drug. The FDA said that it did not have sufficient data to determine the safety and efficacy of the generic drug. The FDA has decided that the company’s product labeling should not contain “ZYPREXA®.”
The FDA announced that it had concluded that the company’s product labeling for the generic drug, marketed as Zyprexa, does not contain the information contained in the patient’s information report for the generic drug’s prescribing information. The FDA also announced that the company’s product labeling for the generic drug, marketed as Seroquel, does not contain the information contained in the patient’s patient information report for the generic drug’s prescribing information. The company’s patent on Seroquel expired in November 2009, leaving the company with the rights to sell the generic drug. The company’s patent on Seroquel expired in October 2010. The company’s patent on Zyprexa expired in December 2009, leaving the company with the rights to sell the generic drug.
On November 6, 2010, the FDA announced that it had concluded that the company’s product labeling for the generic drug, marketed as Olanzapine, does not contain the information contained in the patient’s information report for the generic drug. The FDA has decided that the company’s product labeling for the generic drug, marketed as Zyprexa, does not contain the information contained in the patient’s information report for the generic drug. The company’s patent on Zyprexa expired in November 2009, leaving the company with the rights to sell the generic drug. The company’s patent on Zyprexa expired in October 2010, leaving the company with the rights to sell the generic drug.
The FDA has approved the new formulation of Zyprexa and Seroquel, along with several other medications and therapies. The drug was approved to treat schizophrenia in December 2010. On February 27, 2011, the FDA approved Zyprexa, Seroquel, and the first generic form of Zyprexa, for the treatment of major depressive disorder. On August 31, 2011, the FDA announced that it had concluded that the company’s product labeling for Zyprexa contains incorrect information about the efficacy and safety of the generic drug. The FDA also announced that the company’s product labeling for Seroquel, marketed as Zyprexa, does not contain the information contained in the patient’s patient information for the generic drug. The company’s product labeling for Zyprexa, marketed as Seroquel, does not contain the information contained in the patient’s information for the generic drug. The company’s patent for Zyprexa expired in October 2010, leaving the company with the rights to sell the generic drug. On August 31, 2011, the company’s patent on Zyprexa expired in October 2010, leaving the company with the rights to sell the generic drug.
Zyprexa (olanzapine) is used to treat people who have mental/mood symptoms (e.g., depression, anxiety, and obsessive-compulsive disorder). It is also used to treat people who are at risk of suicidal thoughts/attempts/suicide/self-injury. Zyprexa (olanzapine) may also be prescribed for purposes other than those listed in this medication guide.
Zyprexa (olanzapine) can be used with or without food.
This medicine is not intended for immediate relief or for the long-term use.
If you have trouble breathing or have a cold, contact your doctor or pharmacist right away.
This medicine may be used for a long time (up to 12 months), but the benefits may be lost if you stop taking it.
Zyprexa (olanzapine) is used for:
Do not take this medicine if you are not sure about your health or are pregnant, planning to become pregnant, or breastfeeding. Do not take this medicine if you have allergies to medicines, foods, or other substances.
Do not take this medicine if you are allergic to:
Read the patient information leaflet provided with this medicine before using this medicine.
Take this medicine in the dose and duration as advised by your doctor or pharmacist. Do not take this medicine more often than directed. If you have trouble breathing or have a cold, contact your doctor or pharmacist.
The amount of time this medicine will work depends on the medicine, meal, and the concentration you take it for. You may need to wait several weeks before noticing a difference. To help you remember, take this medicine at about the same time each day. If you miss a dose, take it as soon as possible and continue with your regular schedule. However, if it is time to have your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed dose.
Do not take this medicine with any of the following:
Zyprexa (olanzapine) may rarely cause drowsiness or dizziness, especially when the medicine is used with alcohol. Do not drive or operate machinery until you know how this medicine will affect you. Alcohol can make you drowsy, so it is important to stay alert and follow the directions for use. If you forget to take a dose, take it as soon as possible and continue with your regular schedule. However, if you have missed a dose, skip the missed dose and continue with your regular dosing schedule.
Do not give this medicine to children or teenagers.
Zyprexa is a trusted medication for the treatment of schizophrenia, bipolar disorder, major depressive disorder, and other mental health conditions. It contains the active ingredient olanzapine, which belongs to a class of drugs called atypical antipsychotics.
Zyprexa's function as a atypical antipsychotic that's used to treat several conditions. For instance, it's also used to treat schizophrenia in some cases.
Additionally, it helps to manage the symptoms of bipolar disorder as well as schizophrenia. Zyprexa also helps manage the symptoms of schizophrenia when the person has a manic episode as a way to reduce the chances of getting episodes of this condition being passed on to others.
Zyprexa also helps manage the symptoms of bipolar disorder as well as bipolar mania and bipolar depression disorder as it's used to treat depression. It helps the person maintain mood by decreasing the amount of serotonin in the brain, which can help help the depressive disorder get better or to deal with symptoms of bipolar disorder and depression.
When considering Zyprexa for treating any mental health conditions, several benefits contribute to the decision between other medications depending on the condition. These include:
When considering Zyprexa for treating any mental health conditions, there are several side effects to be aware of.
When considering Zyprexa for treating any mental health conditions, it's essential to have a understanding with your healthcare provider about all of the medications and other treatments that are available to you based on your condition and the medication you've been using. Zyprexa, the class of drugs referred to as atypical antipsychotics, works by stopping the activity of a chemical called serotonin in the brain, which can make it difficult for the brain to make and maintain a balance of neurotransmitters.
Additionally, it can help to manage the symptoms of bipolar disorder as a way to reduce the chances of getting episodes of this condition being passed on to others.
Zyprexa can cause various side effects for a person's treatment depending on their development and age. However, the most common side effects include:
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$22.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
WARNINGS:
Information not available. Zyprexa Tablet is a prescription medicine used for the treatment of psychotic disorders in adults. Zyprexa Tablet may not be used in children and teenagers.
Stade de France Pharmacy